FDA PRO Guidance and ePRO patient reported outcomes solutions with patient eDiaries

Contact Us | US 1.877.360.2901 | EUR 41.22.879.91.00

Follow Us On Twitter  Linkedin Profile        

PHT Home > 2012 PRO & ePRO Congress: Agenda

Program Draft Agenda

Tuesday, 12 June
13:00 - 19:00 Guest Arrival and Registration
19:00 - 22:30 Welcome Reception and Dinner
Wednesday, 13 June
08:00 - 09:00 Breakfast
09:00 - 09:15 Welcome and Introductions

Sheila Rocchio MBA, VP Marketing
PHT Corporation
09:15 - 10:15 The Ten Most Important Developments in the PRO/ePRO Industry

Phil Lee, President & CEO
PHT Corporation
10:15 - 11:15 Measuring Treatment Benefit: Can We Do Better?

Global Regulatory Authority
11:15 - 11:45 Break
11:45 - 12:45 Intermediate ePRO Users: Using ePRO for the First Time
Dr. Darja Turner
Clinical Trial Manager
ESBATech AG


Expert ePRO Users:The Power of ePRO and eSource
Jan Breemans
eClinical Manager
Grunenthal GmbH
12:45 - 14:15 Group Luncheon
14:15 - 15:30 Oxford Debate:

This house believes that regulators should forbid paper from clinical trials.


Julianne Hull
CEO
WenStar Enterprises
Moderator

Jan Breemans, Grunenthal GmbH
Valdo Arnera MD, PHT Corporation
vs
Prof. Olivier Chassany, Hopital Saint Louis
Steve Raymond PhD, PHT Corporation
15:30 - 16:15 Case Study

Sponsor
16:15 - 16:45 Break
16:45 – 17:30 Accessing the 'Fit for Purpose' PRO/ePRO Instrument

Sponsor
17:30 – 17:45 Meeting Wrap & Information on Evening Event

Sheila Rocchio MBA, VP Marketing
PHT Corporation
19:00 - 21:30 Evening Reception & Dinner
Thursday, 14 June
07:00 - 08:30 Breakfast
08:30 - 08:45 Welcome

Sheila Rocchio MBA, VP Marketing
PHT Corporation
08:45 - 09:30 The Advantages / Disadvantages of ePRO Over Paper

Site
09:30 - 10:30 Round Table Discussions

ePRO Compliance: A Respiratory Case Study
What it takes to get a good result, and how to define a successful trial

Donna Reed, PHT Corporation
Kevin Kilminster, Novartis Pharmaceuticals UK Limited
Paul Lafferty, Novartis Pharmaceuticals UK Limited


Operationalizing Clinical Trials in Asia Pacific Region & other Emerging Markets
PRO in Japan
Ami Ishihara, CMIC
10:30 - 11:00 Break
11:00 - 11:45 How ePRO Data can Change Your Trial Outcome

Paulo Carita
Director Quantitative Sciences
Sanofi-Aventis
11:45 - 12:30 New Sensory Measures for ePROs
Steve Raymond PhD,
PHT Corporation
12:30 - 12:45 Meeting Wrap

Sheila Rocchio MBA, VP Marketing
PHT Corporation
12:45 - 14:00Concluding Luncheon
14:00Guest Departures